Neptunus International Holdings

Neptunus International Holdings is a leading Chinese healthcare conglomerate with a comprehensive presence across the pharmaceutical industry value chain. The company operates through several key subsidiaries, most notably Shenzhen Neptunus Bioengineering, which is listed on the Shenzhen Stock Exchange. Its business segments include pharmaceutical R&D, large-scale manufacturing, professional logistics, and an extensive retail pharmacy network. Neptunus produces a wide array of products, including chemical generics, biologics, traditional Chinese medicines, and nutritional supplements. As one of China's most recognized healthcare brands, the group maintains a dominant position in the domestic retail market while pursuing international expansion. The company is headquartered in Shenzhen and continues to invest in innovative drug development and modernized Chinese medicine.